Akèy › Timò sèvo ak mèvèl epinye › Tennessee › Nashville
Etid klinik pou Timò sèvo ak mèvèl epinye nan Nashville, TN
7 etid pou Timò sèvo ak mèvèl epinye ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of PHST001 in Advanced Solid Tumors
Ap rekriteFaz 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Ap rekriteFaz 1/2
- Vanderbilt University Medical Center, Nashville
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Ap rekriteFaz 1/2
- SCRI Oncology Partners, Nashville
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
Ap rekriteFaz 2
- SCRI Oncology Partners, Nashville
Cabozantinib for Patients With Recurrent or Progressive Meningioma
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Nashville
Etid Timò sèvo ak mèvèl epinye nan lòt vil
- New York City, NY10 etid
- Houston, TX9 etid
- Boston, MA7 etid
- Philadelphia, PA7 etid
- Los Angeles, CA6 etid
- Washington, DC6 etid
- Dallas, TX5 etid
- Seattle, WA5 etid
- Atlanta, GA5 etid
- Columbus, OH5 etid
- Chicago, IL5 etid
- Durham, NC5 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.